Protein A Resin

SEATTLE, WASHINGTON, UNITED STATES, February 3, 2022 /EINPresswire.com/ -- 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐀 𝐑𝐞𝐬𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭

𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

Natural protein A is a chemical component extracted from bacterial cell of staphylococcus aureus species. It is typically used in the purification of monoclonal antibodies in large-scale industries across the biotechnology sector.

The global protein A resin market is estimated to account for US$ 511.7 Mn in terms of value in 2020 and is expected to reach US$ 907.3 Mn by the end of 2027.

𝐃𝐫𝐢𝐯𝐞𝐫𝐬

Growing launch of new products is expected to boost the global protein A resin market growth over the forecast period.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/231

𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬

Rising approval and launch of biosimilars can present lucrative growth opportunities for marketers in the near future. For instance, in May 2018, Pfizer, Inc., a U.S.-based pharmaceutical company, received the U.S. Food and Drug Administration (FDA) approval for RETACRIT, which is a biosimilar to Epogen and Procrit. It is the first and only the U.S. FDA approved biosimilar erythropoiesis-stimulating agent.

𝐑𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬

Continuous research and development activities on bi-specific antibodies and antibody fragments are expected to restrain growth of the global protein A resin market during the forecast period. Biopharmaceutical companies are focused on R&D activities on antibodies fragments and bi-specific antibodies. Furthermore, these antibodies also exhibit promising results in the various therapies such as monoclonal antibodies. However, purification of these antibodies requires protein L instead of protein A, due to lack of fragment crystallisable region.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬

The global protein A resin market was valued at US$ 474.0 Mn in 2019 and is forecast to reach a value of US$ 907.3 Mn by 2027 at a CAGR of 8.5% between 2020 and 2027. Major factor driving the growth of global protein A resin market during the forecast period include technological advancement, and increasing approvals of monoclonal antibodies.

Natural Protein A held dominant position in the global protein A resin market in 2019, accounting for 63.1% share in terms of value, followed by Recombinant Protein A, respectively.

𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/231

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬

Continuous R&D activities in rapid prototyping is an emerging trend in the global protein A resin market. For instance, in June 2020, researchers from Vilnius University, Lithuania, reported employing a single bio-based resin derived from soy beans, suitable for optical 3D printing in the scales from nano- to macro-dimensions, which can be processed even without the addition of photoinitiator.

Key companies are focused on investing in expansion of manufacturing capabilities, in order to expand the market presence. For instance, in July 2018, GenScript Biotech Corporation announced to invest US$ 75 million to establish a modern biologics discovery, development, clinical and commercial manufacturing center in the city of Zhenjiang, Jiangsu Province, China.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐒𝐞𝐜𝐭𝐢𝐨𝐧

Major players operating in the global protein A resin market include, 𝗚𝗘 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲, 𝗧𝗵𝗲𝗿𝗺𝗼 𝗙𝗶𝘀𝗵𝗲𝗿 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰, 𝗥𝗲𝗽𝗹𝗶𝗴𝗲𝗻, 𝗧𝗼𝘀𝗼𝗵 𝗕𝗶𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲, 𝗘𝗠𝗗 𝗠𝗶𝗹𝗹𝗶𝗽𝗼𝗿𝗲, 𝗡𝗼𝘃𝗮𝘀𝗲𝗽, 𝗚𝗲𝗻𝗦𝗰𝗿𝗶𝗽𝘁 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗖𝗼𝗿𝗽𝗼𝗿𝗮𝘁𝗶𝗼𝗻, 𝗣𝘂𝗿𝗼𝗹𝗶𝘁𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀, 𝗮𝗻𝗱 𝗘𝘅𝗽𝗲𝗱𝗲𝗼𝗻 𝗟𝘁𝗱.

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

Key players are involved in capacity expansion for R&D activities, in order to gain a competitive edge in the market. For instance, in June 2020, Avantor, Inc. announced the expansion of the company's Bridgewater, N.J. (U.S) innovation center.

𝐓𝐨 𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/231

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

• 𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

o Natural Protein A
o Recombinant Protein A

• 𝐁𝐲 𝐌𝐚𝐭𝐫𝐢𝐱 𝐓𝐲𝐩𝐞

o Agarose-based
o Glass or Silica Based
o Organic Polymer Based

• 𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

o Immunoprecipitation (IP)
o Antibody Purification

• 𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫

o Biopharmaceutical Manufacturers
o Clinical Research Laboratories
o Academic Institutes

• 𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧

o North America
o Latin America
o Europe
o Asia Pacific
o Middle East
o Africa

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.